Laboratory Screening for Side Effects of Disease Modifying Antirheumatic Drugs in Daily Rheumatological Practice

Author： Simon C. H   Vliet Vlieland Th. P. M   Dijkmans B. A. C   Moens Bernelot   Janssen M   Hazes J. M. W   Franken H. C. M   Vandenbroucke J. P   Breedveld F. C  

Publisher： Informa Healthcare

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.27, Iss.3, 1998-08, pp. : 170-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis

By Rodriguez-Rodriguez L   Jover-Jover JA   Fontsere O   Peña-Blanco RC   León L   Fernández-Gutierrez B   Abásolo L  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 6, 2013-11 ,pp. : 433-436

Informa Healthcare

Access to resources Recommend Favorite

Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up

By Tiippana-Kinnunen T   Paimela L   Kautiainen H   Laasonen L   Leirisalo-Repo M  

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 1, 2010-05 ,pp. : 12-18

Informa Healthcare

Access to resources Recommend Favorite

Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

By Tan Jing  

Clinical Rheumatology, Vol. 31, Iss. 8, 2012-08 ,pp. : 1169-1175

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent infections in a rheumatoid arthritis patient with a primary immunodeficiency, treated with conventional and biologic disease-modifying anti-rheumatic drugs

By Diamantopoulos Andreas  

Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. : 295-297

Springer Publishing Company

Access to resources Recommend Favorite

Disease-modifying anti-rheumatic drugs for refractory severe knee synovitis in patients with peripheral spondyloarthritis: efficacy and predictors of response

By Sakellariou GT   Sayegh FE   Anastasilakis AD   Bisbinas I   Kapetanos GA  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 5, 2013-10 ,pp. : 369-372

Informa Healthcare

Access to resources Recommend Favorite